The treatment could benefit 500 people with follicular lymphoma

Updated Date: Wed, 06 May 2020 00:00:00 EDT

Updated Date: Wed, 06 May 2020 00:00:00 EDT

Updated Date: Wed, 06 May 2020 00:00:00 EDT

Updated Date: Wed, 06 May 2020 00:00:00 EDT

Updated Date: Wed, 06 May 2020 00:00:00 EDT

Back in January, Merck said Keytruda—its anti-PD-1 therapy—had missed the mark in small cell lung cancer, an area […]

Pfizer and Astellas’ Xtandi is already approved to treat non-metastatic castration-resistant prostate cancer, thanks to data showing it […]

The medical research world is responding to the covid-19 pandemic at breathtaking speed. There has been a maelstrom […]

AbstractObjectiveTo estimate and compare progression rates to type 2 diabetes mellitus (T2DM) in women with gestational diabetes mellitus […]